UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039676
Receipt number R000045242
Scientific Title Verification of the effect of aroma on exercise characteristics-Group comparison study-
Date of disclosure of the study information 2020/03/04
Last modified on 2020/09/02 11:47:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification of the effect of aroma on exercise characteristics-Group comparison study-

Acronym

Verification of the effect of aroma on exercise characteristics

Scientific Title

Verification of the effect of aroma on exercise characteristics-Group comparison study-

Scientific Title:Acronym

Verification of the effect of aroma on exercise characteristics

Region

Japan


Condition

Condition

Healthy

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Verification of changes in exercise characteristics by aroma

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Exercise test
(Odorless control,Aroma A,Aroma B)

Key secondary outcomes

Psychological examination
(Odorless control,Aroma A,Aroma B)


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Aroma A:Sticker
Once

Interventions/Control_2

Aroma B:Sticker
Once

Interventions/Control_3

Odorless target:Sticker
Once

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

59 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Male and female aged 30 to 59 years old at the time of the informed consent
2.No smoking (past smoking experience is acceptable)
3.No aroma use
4.Healthy (No problem in the preliminary inspection)
5.No history of hospitalization / visit within 1 year
6.Have received the health checkup for 2019 and have no problem(Minor abnormalities and follow-up observations are within the standard)
7.BMI value between 18.5 and 30
8.No abnormalities in wrist or back condition (injuries, numbness, paralysis, etc.)
9.No problem with physical condition (electrocardiogram, blood pressure, pulse, body temperature) on the day of the test, and the doctor's interview, and who is considered to be inappropriate to attend the present study by the investigator
10.Applicants who receive a sufficient explanation of the purpose and content of this study, have the ability to consent, have a good understanding, volunteer to participate, and agreed to participate in this study
11.Subjects who can come on the designated inspection day and can be inspected

Key exclusion criteria

1.Subjects who check in the range of 25% from very dislike in the VAS type questionnaire with scent taste (very dislike-very like)
2.Subjects under 30 and over 60
3.Subjects who is currently going to the hospital and are under treatment
4.Subjects with mental disorders
5.Subjects under medication
6.Subjects who are pregnant or possibly pregnant, or lactating
7.Abnormality found in ECG check
8.Subjects who has high blood pressure / low blood pressure (except systolic blood pressure 90-135mmHg)
9.Subjects who has tachycardia (pulse rate over 90 beats / min)
10.Subjects with respiratory, circulatory, otolaryngological diseases (including chronic sinusitis), or orthopedic diseases
11.Subjects who cannot smell the aroma
12.Subjects with smoking habits
13.Subjects who drink a large amount of alcohol every day (1500ml / day for beer, 3go / day for sake, 2go / day for shochu)
14.Subjects who may show allergic symptoms by the test product (or person who have allergic symptoms)
15.Subjects who prefer unscented and subjects who do not like aroma (have aversion to menthol (e.g., scents such as VICKS vaporub)
16.Subjects who use aroma in daily life * Aroma is the use of a diffuser, aroma lamp, etc. take an aromatic bath such as essential oils.
17.Subjects with physical pain which causes problems in daily life
18.Those who cannot walk for more than 10 minutes without resting in everyday walking
19.Subjects who have difficulty going up and down the stairs
20.Subjects who cannot ride a bicycle for more than 20 minutes
21.Subjects who are left-handed
22.Subjects who are participating in other clinical studies
23.Subjects who have problem with the physical condition measurement on the day of the testing or a doctor's interview, and are judged by the investigator to be inappropriate for this study
24.Subjects who are considered to be inappropriate to attend the present study by the investigator

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Yoshihisa
Middle name
Last name Abe

Organization

FANCL Corporation

Division name

Research Institute

Zip code

244-0806

Address

12-13 Kamishinano, Totuska-ku, Yokohama, Kanagawa, Japan

TEL

045-820-3891

Email

Ay0272@fancl.co.jp


Public contact

Name of contact person

1st name Toshiaki
Middle name
Last name Imasu

Organization

FANCL Corporation

Division name

Research Institute

Zip code

244-0806

Address

12-13 Kamishinano, Totuska-ku, Yokohama, Kanagawa, Japan

TEL

045-820-3868

Homepage URL


Email

toimasu@fancl.co.jp


Sponsor or person

Institute

FANCL Corporation

Institute

Department

Personal name



Funding Source

Organization

FANCL Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ueno-Asagao Clinic Ethical Review Committee

Address

6F Kairaku Building 2-7-5 Higashiueno Taito-ku Tokyo 110-0015, JAPAN

Tel

03-6240-1162

Email

jimukyoku@tes-h.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

うえのあさがおクリニック


Other administrative information

Date of disclosure of the study information

2020 Year 03 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

24

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 01 Month 23 Day

Date of IRB

2020 Year 01 Month 23 Day

Anticipated trial start date

2020 Year 03 Month 04 Day

Last follow-up date

2020 Year 03 Month 06 Day

Date of closure to data entry

2020 Year 03 Month 13 Day

Date trial data considered complete

2020 Year 03 Month 19 Day

Date analysis concluded

2020 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2020 Year 03 Month 03 Day

Last modified on

2020 Year 09 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045242


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name